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Abstract
Introduction Taking microdoses (a mere fraction of normal doses) of psychedelic substances, such as truffles, recently gained
popularity, as it allegedly has multiple beneficial effects including creativity and problem-solving performance, potentially
through targeting serotonergic 5-HT2A receptors and promoting cognitive flexibility, crucial to creative thinking. Nevertheless,
enhancing effects of microdosing remain anecdotal, and in the absence of quantitative research onmicrodosing psychedelics, it is
impossible to draw definitive conclusions on that matter. Here, our main aim was to quantitatively explore the cognitive-
enhancing potential of microdosing psychedelics in healthy adults.
Methods During a microdosing event organized by the Dutch Psychedelic Society, we examined the effects of psychedelic
truffles (which were later analyzed to quantify active psychedelic alkaloids) on two creativity-related problem-solving tasks: the
Picture Concept Task assessing convergent thinking and the Alternative Uses Task assessing divergent thinking. A short version
of the Ravens Progressive Matrices task assessed potential changes in fluid intelligence. We tested once before taking a
microdose and once while the effects were expected to be manifested.
Results We found that both convergent and divergent thinking performance was improved after a non-blinded microdose,
whereas fluid intelligence was unaffected.
Conclusion While this study provides quantitative support for the cognitive-enhancing properties of microdosing psychedelics,
future research has to confirm these preliminary findings in more rigorous placebo-controlled study designs. Based on these
preliminary results, we speculate that psychedelics might affect cognitive metacontrol policies by optimizing the balance between
cognitive persistence and flexibility. We hope this study will motivate future microdosing studies with more controlled designs to
test this hypothesis.
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Introduction
Major news outlets throughout the world are reporting on the
growing number of professionals using small doses of psy-
chedelics (e.g., magic mushrooms, truffles, or peyote) to boost
their productivity and creativity at work. A prominent exam-
ple is the use of small doses of LSD by employees in Silicon
Valley, as a Bproductivity hack^ (Glatter 2015). This emerging
phenomenon is referred to as microdosing, with dosages
around one tenth of recreational doses. Yet, despite the low
dosages, microdosing is still thought to provide a potential
boost in cognition according to anecdotal reports (Cooke
2017; Gregorie 2016; Leonard 2015; Sahakian 2017; Senior
2017; Solon 2016). Moderate to large doses of psychedelics
induce changes in perception, mood, and overall conscious-
ness, often described as qualitatively similar to deep medita-
tive or transcendental states (Barrett and Griffiths 2017;
Barrett et al. 2017). If similar, yet substantially more subtle,
effects apply to microdosing, this would render microdosing a
potentially interesting cognitive enhancer in healthy individ-
uals or even the basis of a treatment strategy to tackle various
disorders including depression.
Throughout the 1960s, psychedelics were extensively used
at recreational doses in experimental research, clinical set-
tings, and in creative and scientific vocations (Sessa 2008),
but were made illegal in most countries worldwide as a reac-
tion to the rising counterculture of the 1960s and failure to
establish the clear efficacy of LSD treatment (Oram 2014).
Now, after many decades of disregard, psychedelics have
started to reappear as a genuine and promising area of research
within experimental and clinical psychology, as well as psy-
chiatry. Moreover, certain psychedelics, such as truffles, have
regained a legal status in The Netherlands, offering re-
searchers a particularly interesting opportunity to study its
effects in a quantitative manner. This is highly desirable, as
previous reports have remained anecdotal (Oberhaus 2017)
and qualitative at best, often focusing on experiences of ele-
vated feelings of determination, alertness, and energy, im-
proved pattern recognition, as well as strong reductions of
depressive feelings (Fadiman and Krob 2017). Qualitative
studies based on self-reports are known to suffer from validity
problems due to participants’ inaccurate memories, differ-
ences in vocabulary and verbal skills, and unintentional or
willful distortions of subjective experiences (Schwarz 1999).
Nonetheless, existing research with moderate doses of psi-
locybin shows that psilocybin is a potent neuro-
pharmacological agent with a strong modulatory effect on
brain processes (Vollenweider and Kometer 2010).
Furthermore, a double-blind placebo-controlled study by
Hasler et al. (2004a, b) showed that even very low doses of
psilocybin (45 μg/kg body weight) were rated clearly psycho-
active by most of the volunteers, which indicates that psyche-
delic effects do not need high doses to be recognized.
Classical psychedelics such as psilocybin (O-phosphoryl-
4-hydroxy-N, N-dimethyltryptamine), the active compound in
psychedelic truffles, exert their primary effects by directly
binding to serotonin 2A receptors (5-HT2A; Tylš et al. 2014).
Interestingly, 5-HT2A agonism has been reported to be asso-
ciated with enhanced cognitive flexibility (Clarke et al.
2004, 2007; Boulougouris et al. 2008; Kehagia et al. 2010),
improved associative learning (Harvey 1995, 2003), and hip-
pocampal neurogenesis (Catlow et al. 2016) in animals.
Additionally, psychedelics have been shown to increase sub-
jective sense of wellbeing, optimism, and openness in humans
(Griffiths et al. 2006, 2008; MacLean et al. 2011). Moreover,
multiple clinical trials using moderate to large doses of psy-
chedelics have indicated that psychedelics have anxiolytic,
anti-depressant (dos Santos et al. 2016; Carhart-Harris et al.
2016a, b; Grob et al. 2011; Griffiths et al. 2016), anti-
compulsive (Moreno et al. 2006), and anti-addictive proper-
ties (Bogenschutz et al. 2015; Johnson et al. 2014; Krebs and
Johansen 2012; dos Santos et al. 2016). Consequently, the
effects of psychedelic substances can be argued to target the
serotonergic system and hence be beneficial in situations
where there is a need for mental flexibility, or where one needs
to break through rigid patterns of thought. In case that future
research confirms positive effects of microdosing on brain and
cognition, microdosing could become an attractive alternative
due to its more subtle nature possibly sparing individuals from
the perceptual distortions often reportedwithmoderate or high
doses.
Through the alleged benefits in mental flexibility, a prom-
ising behavioral target of psychedelics lies in the area of cre-
ativity. Creativity is a multilayered phenomenon, commonly
defined as the ability to generate ideas, solutions, or products
that are both novel and appropriate (e.g., Amabile 1996;
Sternberg and Lubart 1999). Creativity is not a unitary func-
tion but consists of a number of subcomponents (Wallas 1926)
that provide different, to some degree opposing cognitive
challenges. It is crucial to distinguish between convergent
thinking, which requires identification of a single solution to
a well-defined problem (Mednick 1962), and divergent think-
ing, which requires the collection of many possible solutions
to a loosely defined problem (Guilford 1967). An example of
convergent thinking task would be to find the one concept that
can be meaningfully combined with three other concepts such
as B…man,^ B…market,^ and B…bowl^ (such as Bsuper^),
while an example of divergent thinking task would be to list
all possible ways in which a brick could be used (for throwing,
as a weight, as a weapon, etc.). It has been argued that con-
vergent thinking draws more on the ability to focus exclusive-
ly on a given problem (persistence), while divergent thinking
draws more on cognitive flexibility (Lippelt et al. 2014).
However, it is important to point out that all available creativ-
ity tasks require the integration of both of these abilities to
some degree. Of further importance to our present study is
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the fact that creative thinking is not a hardwired virtue. Several
behavioral studies have shown that the processes underlying
creative thinking can be systematically enhanced and im-
paired by both behavioral interventions, such as meditation,
as well as, psychopharmacological agents, as for instance can-
nabis, tyrosine, and Adderall (e.g., Baas et al. 2014; Colzato
et al. 2015; Farah et al. 2009; Kowal et al. 2015; Ritter and
Mostert 2016; Schafer et al. 2012; Zabelina and Robinson
2010; Davis 2009).
Moreover, a recent study conducted by Kuypers et al.
(2016) investigated the effect of recreational doses of the psy-
chedelic brew Ayahuasca on creativity during two spiritual
retreats. They found that divergent thinking performance im-
proved under the influence of Ayahuasca compared to base-
line, while convergent thinking performance decreased in
comparison to baseline. Although this study may seem to
provide a useful starting point, conclusions are hampered by
several disadvantages of this drug and the study design. First,
dimethyltryptamine (DMT), the active psychedelic compound
in Ayahuasca, needs to be combined with monoamine oxidase
inhibitors (MAOIs) for its effect to take place. MAOIs are
known to have anti-depressant effects on their own, so they
represent a possible confound in all Ayahuasca studies
(Quitkin et al. 1979). Additionally, this implies that the qual-
itative experience induced by large doses of Ayahuasca and
the underlying mechanisms of action are likely to differ sub-
stantially from psychedelic experience induced by
microdosing for which LSD or psilocybin are commonly used
(Callaway and Grob 1998; Riba et al. 2006). Indeed, the
Ayahuasca brews used in the study of Kuypers et al. (2016)
induced strong psychedelic experiences, the effects of which
are unlikely to be comparable to the effects obtained from
microdosing a psychedelic substance. High doses of psyche-
delics frequently result in disorienting effects in the user,
which makes reliable assessment of psychometric task perfor-
mance difficult during the peak effects of the psychedelic ex-
perience (Hollister 1968). Taken altogether, microdosing of
psychedelic truffles and related psychoactive substances may
thus be more suitable to assess the enhancing effects of psy-
chedelics on human performance.
The current study is the first to experimentally investigate
the cognitive-enhancing effects of microdosing on human cog-
nition in a natural setting. We were offered the unique oppor-
tunity to quantitatively study the effects of microdosing truffles
during microdosing events of the Psychedelic Society of
The Netherlands (PSN), a non-laboratory environment.
Natural settings like such an event have a number of potential
benefits as they are more comparable to situations of real life
use than studies in a laboratory environment. The truffle sam-
ples, which participants obtained during the microdosing event,
were post hoc analyzed, to determine the exact amount of active
substance potentially leading to the found effects. The major
aim of our study was to study the effects of psychedelic truffles
on creative thinking. We assessed convergent and divergent
thinking separately, by using the Picture Concept Task (PCT)
(Hurks et al. 2010; Wechsler 2003) and Guilford’s (1967)
Alternate Uses Task (AUT), respectively. Given that conver-
gent thinking is correlated with fluid intelligence (e.g., Akbari
Chermahini et al. 2012), we also employed a short 12-item
version of Raven’s Progressive Matrices Task (Bilker et al.
2012), a standard intelligence test, once before and while the
acute effects were expected to take place. Given the effects of
large doses of psychedelics on positive mood, trait openness,
and assumed cognitive flexibility reflected by psychosis-like
symptoms (Carhart-Harris et al. 2016a, b), we expected im-
provements on the AUT after microdosing, as mood and flex-
ibility are two factors that are known to boost divergent think-
ing (Baas et al. 2008; De Dreu et al. 2008; Vosburg 1998;
Zabelina and Robinson 2010). Due to a lack of relevant previ-
ous studies and the subjectivity of self-reports, the effect on
convergent thinking was difficult to predict. On the one hand,
previous dissociations of convergent and divergent thinking
might suggest that convergent thinking is impaired by
microdosing—an outcome that could imply that microdosing
shifts cognitive control states from persistence to flexibility
(Hommel 2015). However, microdosing may also improve
both convergent and divergent thinking, suggesting that
microdosing improves the interplay between persistence and
flexibility. We did not have specific expectations regarding in-
telligence, but were interested to see whether possible effects on
convergent thinking might generalize to performance on the
intelligence task or remained more specific.
Methods
Procedure
The experiment was conducted during a microdosing event
organized by the Psychedelic Society of the Netherlands
(PSN), who provided us with the opportunity to ask partici-
pants to take part in the experiment by means of an on-stage
presentation. Interested participants were presented with en-
velopes containing the informed consents. We asked partici-
pants to read the provided information carefully, to sign it if
they gave permission for their participation and use of their
anonymized, coded data, and to subsequently return it back in
the envelope. The envelope also included the experimental
tasks for the first session as a booklet. However, we stressed
participants to not open the booklet until one of the experi-
menters asked them to turn the first page to prevent premature
exposure to the tasks. The experimenters also kept a close eye
on the attendees to further ensure participant compliance.
Next, all participants were carefully guided through the exper-
imental tasks. Each task was explained in detail by one of the
experimenters with the aid of example items, before
Psychopharmacology
participants were allowed to perform the task themselves. This
was repeated for each of the three tasks. The protocol was
approved by the local ethics committee (Leiden University,
Institute of Psychology). The experiment consisted of a base-
line session before participants had consumed any psyche-
delics and a second session carried out while participants were
under the influence of a microdose of psychedelic truffles. The
tasks were conducted in a group setting free from outside
distraction during both sessions. Participants’ responses were
assessed in paper-and-pencil version. The test battery
consisted of the Picture Concept Task (PCT) (Wechsler
2003; Hurks et al. 2010) to assess convergent thinking, the
Alternate Uses Task (AUT) (Guilford 1967) to assess diver-
gent thinking, and a validated short 12-item version of the
Raven’s Progressive Matrices Task (RPM) (Bilker et al.
2012) to test fluid intelligence. While AUT and RPM were
presented fully in paper version, PCT stimuli were presented
by PowerPoint to insure precise timing of stimuli presentation
(further details about the contents of the psychometric tasks
are provided under the BMaterials^ section). Pre- and post-
microdosing performance was assessed by administering
two different versions of each task, to reduce potential learn-
ing effects. Task versions were counterbalanced across ses-
sions and participants.
After finishing the experimental tasks in the first session,
participants consumed a microdose of pre-measured psyche-
delic truffles made available by the PSN. Participants of the
workshop agreed to take psychedelic truffles upon their own
risk. The PSN did not adhere to any strict guidelines regarding
the dosage given to attendees. Nonetheless, they did take the
attendees self-reported approximate weight into account in
their recommended dosage, by means of subjective evalua-
tions regarding low, average, and high body weight criteria.
Attendees judged to have a low body weight were recom-
mended to take 0.22 g of truffles, those with an average body
weight 0.33 g, and those with a high body weight were rec-
ommended 0.44 g of dried truffles. Moreover, it should be
noted that attendees did not have to adhere to the PSN mem-
ber’s recommendation and were free to choose a dose.
However, with reference to the existing microdosing guide-
lines (Fadiman 2011), the doses provided to participants ap-
peared to be in a meaningful range of a microdose. Following
the publication of The Psychedelic Explorer’s Guide
(Fadiman 2011), a microdose should lie around one tenth to
one sixteenth of a regular dose. Considering that a recreational
dose of truffles is about 10 g of fresh truffles, a microdose
would equal 1 g of fresh truffles. As fresh truffles consist of
two thirds of water, this results in a weight of 0.33 g of dried
truffles. Participants consumed on average 0.37 of dried truf-
fles which is an appropriate amount given the calculation.
Additionally, data on participants’ height, body weight, and
ingested dose of truffles were independently collected by the
researchers in order to examine potential dose-dependent ef-
fects in the analysis.
Approximately 1.5 h after attendees had consumed the
truffles, participants were asked to take part in the second
session of the experiment. The 1.5-h time interval was chosen
as the effects of truffles are reported to peak around 30–90min
followed by a few hours long plateau of effects before rapidly
subsiding back to baseline (Erowid 2017). By choosing this
time interval, we could be certain that all participants were
tested while the effects of the truffles were still plateauing
during the second session. The procedure during the first ses-
sion was repeated at the second session. Lastly, participants
filled in a questionnaire on medical health, psychedelic and
general drug use, and general personal information (e.g., gen-
der, age, first language). After testing, we thanked participants
for their participation and debriefed them about the purpose of
our experiment.
Sample
Out of all 80 attendees at the microdosing event, 38
volunteered in our experiment. Participants indicated that they
were healthy, spoke the required languages for performing the
experimental tasks, and whether they had prior experience
with the use of psychedelic substances. All 38 participants
completed the RPM during both sessions. Regarding the
PCT, 11 participants had to be excluded from further analysis,
either due to incorrect interpretation of the task instructions or
because they did not complete the task either for the first or
second session. For the AUT, two participants had to be ex-
cluded as the experimenters were unable to read the individ-
uals’ writing: two due to missing data on the second session
and one due to misinterpretation of the task instructions.
Importantly, the individuals that were excluded for the AUT
and PCTanalysis did not overlap. This suggests that exclusion
was random and did not depend on a shared trait or state
among those who were excluded from the two analyses.
Nonetheless, in order to preserve power, we decided to ana-
lyze the data separately for each task. This yielded a sample of
38 participants for the analyses of the RPM data, 27 subjects
for the PCTanalyses, and 33 for the analyses of the AUT data.
Table 1 provides an overview of additional descriptive infor-
mation regarding the sample.
Truffle analysis
Dried truffle samples of what participants used during the
microdosing event (corresponding to 0.22, 0.33, or 0.44 g
dry weight) were post hoc analyzed at the University of
Chemistry and Technology Prague (UCT; Laboratory of
Biologically Active Substances and Forensic Analysis) to de-
termine the exact amount of active substances potentially
leading to the found effects. Analytical standards of psilocin,
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psilocybin, norbaeocystin, and baeocystin were synthesized
in-house (purity ≥ 95%) at UCT. The evaluation of the devel-
oped analytical method (Hajkova et al. 2016) encompassed
the determination of Limit of Quantitation (LOQ) and the
determination of the applicable concentration range for each
compound studied. LOQ was determined as 10 times the ratio
of signal to noise. Concentration was determined for each of
the truffle samples separately, and each sample was measured
twice. The level of the alkaloids was almost identical in all
three samples, however, and the differences were lower than
the estimated measurement errors when the results from the
different samples are averaged. As such, we report the con-
centrations for the four alkaloids collapsed across the three
samples in the results. For the alkaloid concentrations for the
three samples separately and further details regarding the
methods underlying these analyses, please see Online
Resource 1.
Despite psilocybin usually being the most abundant alkaloid
in psychedelic truffle psilocin is commonly considered to be
responsible for the psychedelic truffles’ characterizing psycho-
active effects (Gartz et al. 1994; Tylš et al. 2014). Psilocybin is
quickly metabolized into psilocin in the human body through
dephosphorylization, thereby limiting psilocybin’s direct contri-
bution to the psychoactive effects in humans. Furthermore, we
also report the concentrations of baeocystin and norbaeocystin
as it has recently been suggested that they could quickly me-
tabolize into corresponding N-demethylated psilocin deriva-
tives upon consumption through similar processes as are at play
in the metabolism of psilocybin (Tylš et al. 2014).
Instruments
Picture concept task
The PCT (Wechsler 2003; Hurks et al. 2010) is a visual crea-
tivity task that involves finding a common association be-
tween several images. Each trial consists of a matrix of be-
tween 2 × 3 to 3 × 4 pictures (see Fig. 1 for an example). The
correct solution is a common association between one picture
from each row. Thus, a response indicating an association
between two pictures from the same row would be incorrect.
Because the task presumes there is only one correct solution to
each item, the task has been previously used to measure con-
vergent thinking (Hurks et al. 2010). Hence, to complete the
task, one should converge on the correct solution, while
inhibiting inappropriate or less obvious associations and pre-
viously attempted yet incorrect solutions.
Participants had 30 s per item to find the solution. Because
precise time limit is essential in this task, it was impractical to
present the task on paper. Instead, we used a PowerPoint pre-
sentation in which the slides (i.e., items) transitioned every
30 s. Participants were instructed to mark and name the com-
mon association between the pictures on the PCT response
sheet in the booklet (see Fig. 2 for a corresponding answer
sheet belonging to the item in Fig. 1). The PCTwas scored by
summing the number of correct responses.
Alternate Uses Task
The AUT is commonly used in research on creativity to mea-
sure divergent thinking performance (Guilford 1967). During
the AUT, subjects are presented with a common household
object and asked to think of as many possible uses for the
object as they can within a limited amount of time. Within
each session of our experiment, participants were either pre-
sented with the word Pen or the word Towel and given 5 min
(per session) to write down as many possible uses for the
object. As common, the AUT was rated according to four
different variables:
& Fluency: the total number of responses
& Flexibility: the number of different categories of responses
& Elaboration: how much the person elaborates on their re-
sponse. Each Belaboration^ receives one point. For in-
stance, the response Busing a brick to prevent a door from
Fig. 1 Example trial from the Picture Concept Task. The subject has to
identify the common association between one item from each row
Table 1 Descriptive statistics for
the samples used in the three
separate analyses. Numbers
indicate mean (SD), unless
otherwise specified (gender and
prior experience)
Sample Age Gender
(M/F)
BMI Weight (kg) Prior experience
(Y/N)
Ingested dosage
(g)
RPM 31.1 (11.49) 23/15 22.5 (4.74) 68.4 (12.81) 36/2 0.37 (0.159)
AUT 30.0 (10.89) 19/14 22.4 (4.92) 67.5 (13.01) 31/2 0.35 (0.142)
PCT 31.5 (12.49) 18/9 22.9 (5.42) 69.3 (13.36) 25/2 0.41 (0.158)
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slamming shut (1), when it is windy (2)^ earns two elab-
oration points.
& Originality: the uniqueness of a response. Originality is
calculated by dividing the total number of responses by
all subjects, once by 5% and once by 1%. Responses that
have also been mentioned by 1% or less of the other par-
ticipants receive two points for originality, while re-
sponses that have been mentioned by 1–5% of the partic-
ipants receive one point for originality. All other responses
receive no originality points.
Out of these four, flexibility is the most reliable and theo-
retically most transparent index of divergent thinking (Akbari
Chermahini and Hommel 2010), while fluency neglects the
quality of responses and the originality score is highly sample-
dependent. As the scoring of AUT variables can be highly
subjective, we used the mean score for each of the four mea-
sures obtained from two independent raters to increase the
reliability of the dependent measures. Reliability scores
(Cohen’s κ) were very high for fluency (session 1, κ = .970;
session 2, κ = .935), fair for flexibility (session 1, κ = .342,
session 2, κ = .252), fair to moderate for elaboration (session
1, κ = .231; session 2, κ = .547), and fair for originality (ses-
sion 1, κ = .254; session 2, κ = .318).
Raven’s Progressive Matrices
The RPMwas developed by Raven (1938) in order tomeasure
fluid intelligence. We used a shortened 12-item version of the
RPM to reduce testing time and participant burden. The 12-
item version was developed and validated by Bilker and col-
leagues (2015) showing high correlations with the full RPM
(r = .80 for version A and r = .77 for version B).
In our experiment, the RPM consisted of a series of 2 × 2 or
3 × 3 matrices of pictures in which the lower right picture was
always missing. Both horizontally and vertically, a pattern is
present in the matrix of pictures allowing the participant to
deduce what the missing picture should look like.
Underneath each item, six possible solutions were presented
and participants marked the correct solution by circling it on
paper. While there was no time limit per item, the task had a
total time limit of 5 min. Throughout, the RPM items in-
creased in difficulty, but participants were allowed to skip an
item in case they felt like they were stuck. However, once they
had advanced to a next item (either by skipping or answering),
they were no longer allowed to go back to correct earlier
responses. The RPMwas also scored by summing the number
of correct responses.
Analyses
First, separate analyses were run to test for possible interac-
tions between time-point (pre- versus post-truffle ingestion)
and participants’ body weight, ingested dose, and prior expe-
rience with psychedelic substances on the dependent mea-
sures. As we did not find any significant interactions, we
dropped these factors from any subsequent analyses. To assess
changes in fluid intelligence, we performed a paired samples t
tests comparing RPM scores at baseline versus RPM scores
post ingestion of the truffles in the entire sample. Next, we
performed a paired sample t test to compare convergent think-
ing performance before and after ingestion for the 27 partici-
pants for whom we obtained valid data on the PCT for both
sessions. To assess microdosing-induced changes in divergent
thinking performance, we analyzed the variables obtained
from the AUT. Although of main interest were the flexibility
and fluency scores, for completeness, we entered all four var-
iables (i.e., fluency, flexibility, elaboration, and originality) as
separate dependent measures in one multivariate Repeated
Measures ANOVA with time (pre- versus post-ingestion) as
the within subject factor. Significant effects in the multivariate
ANOVAwere followed-up by the appropriate univariate tests.
The significance level for all analyses was set to α = .05.
Results
Psychedelic content in truffle sample
The Forensic Laboratory of Biologically Active Substances
confirmed the presence of the active psychedelic alkaloids in
the truffle samples. Quantitative analysis showed the presence
of all four investigated alkaloids with predominant levels of
psilocybin (see Table 2 for an overview of alkaloid
concentrations). The next-most abundant alkaloids were
psilocin followed by baeocystin. The concentrations of the
four alkaloids were almost identical for all three samples,
and the differences were lower than the measurement errors
obtained when the data is collapsed across samples.
In this study, we compared task performance before the
ingestion of the psychedelic truffles with performance approx-
imately 1.5 h after ingestion (i.e., while the effects of the
Fig. 2 Illustration of a filled in answer sheet for the items from Fig. 1
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psychedelic truffles are thought to be fully manifested).
Table 3 displays descriptive statistics for both sessions of per-
formance on all dependent measures.
Interaction effects with weight, body mass index,
ingested dosage, and prior experience
We tested for possible interaction effects on all dependent
measures using Repeated Measures ANOVAs. All Fs were
smaller than 1, except for the interaction with the ingested
dosage on the PCT, F(1, 25) = 1.13, p = .299, and the interac-
tions with prior experience on the PCT, F(1, 25) = 1.05,
p = .316, and RPM, F(1, 36) = 3.69, p = .063. Nevertheless,
these results show that none of the factors significantly
interacted with the independent factor time-point and were
thus dropped from the final analyses described below.
Fluid intelligence
Comparing fluid intelligence on pre- and post-microdosing
using a paired-sample t test, we found no difference between
the two time-points with respect to the number of correct items
on the RPM, t(37) = 1.00, p = .324, Cohen’s d = .163.
Convergent thinking
Performance on the PCT (number of correct responses) was
significantly higher in the second than in the first session,
t(26) = 2.56, p = .017, Cohen’s d = .493, showing an improve-
ment of convergent thinking.
Divergent thinking
The four measures of the AUT were analyzed by means of a
multivariate Repeated Measures ANOVA. The effect of time-
point was significant, F(4, 29) = 4.16, p = .009, partial
η2 = .365, due to better performance in the second than the
first session. Additional univariate tests showed a significant
increase in fluency, F(1, 32) = 5.59, p = .024, partial η2 = .149,
flexibility, F(1, 32) = 6.23, p = .018, partial η2 = .163, and
originality scores, F(1, 32) = 12.03, p = .002, partial
η2 = .273, while the change in elaboration scores failed to
reach significance, F(1, 32) = 2.97, p = .226, partial η2 = .046.
Discussion
The aim of this study was to explore the effects of
microdosing psychedelics on creative problem-solving. We
observed an increase in divergent idea generation on the
AUT, as evidenced by a significant increase in fluency, flexi-
bility, and originality scores, as well as an increase in conver-
gent thinking on the PCT after intake of a microdose of magic
truffles. Given that scores of fluid intelligence did not change
between the two measurement time-points, while we did ob-
serve change in scores in the creativity domain, it is possible
that microdosing targets creativity performance, but not more
general analytic cognition. These findings are in line with
earlier studies finding positive effects of high doses of psy-
chedelics on creative performance (Harman and Fadiman
1970; Kuypers et al. 2016; Zegans et al. 1967). In particular,
the increase in originality scores on the AUT parallels the
increase in originality scores after intake of Ayahuasca report-
ed by Kuypers et al. (2016). Taken together, our results sug-
gest that consuming a microdose of truffles allowed partici-
pants to create more out-of-the-box alternative solutions for a
problem, thus providing preliminary support for the assump-
tion that microdosing improves divergent thinking. Moreover,
we also observed an improvement of convergent thinking, that
is, increased performance on a task that requires the conver-
gence on one single correct or best solution.
Before continuing to interpret our findings, it is important
to consider the implications of the fact that we did not use a
control group (for obvious ethical and practical reasons).
Given the absence of a control group, we cannot rule out the
possibility that changes from the first to the second time-point
of measurement are due to the impact of other factors than the
microdosed truffles. Two of these factors come to mind. For
one, it is possible that increased performance from the first to
the second time-point of measurement reflects learning. We
consider that possibility not very likely, for three reasons.
First, it does not seem to fit with the absence of an improve-
ment for the intelligence measure, even though the Raven task
shares many aspects with the PCT and the AUT. Second,
Table 3 Descriptive statistics (means (SE)) for the first and second
session
Measure Session 1 Session 2
PCT 6.56 (1.601) 7.59 (1.600)
RPM 8.58 (2.238) 8.97 (1.924)
Fluency 14.68 (0.99) 16.70 (1.19)
Flexibility 11.20 (0.80) 12.74 (0.93)
Elaboration 2.18 (0.32) 1.76 (0.28)
Originality 12.36 (1.30) 15.67 (1.45)
Table 2 Results of observed analytes averaged over the three dosages
Alkaloid μg/g (ppm) SD Relative SD (%)
Psilocybin 1595 3.75 2
Psilocin 85 0.86 10
Norbaeocystin 8 0.06 7
Baeocystin 31 0.15 5
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studies on convergent thinking have not shown evidence of
improved performance with multiple testing—at least if dif-
ferent test items were used. For instance, Colzato et al. (2012)
had participants perform the Remote Association Task, which
can be considered a verbal version of the PCT, three times in
different conditions and found neither condition effects nor,
and this would be the learning-sensitive test, any interaction
between condition and condition order. Third, a recent train-
ing study did not reveal any (positive) training effects on AUT
performance (Stevenson et al. 2014). No effect of eight train-
ing sessions was observed for originality; a negative training
effect was obtained for fluency, and a quadratic effect for
flexibility. Both fluency and flexibility measures in fact
decreased over the first three to four sessions, and only the
flexibility measure eventually reached the original baseline in
the 8th session. Taken together, we see no empirical support
for the possibility that our observations might reflect a learn-
ing effect.
For another, it is possible that increased performance from
the first to the second time-point reflects an effect of expecta-
tion. Expectation effects are widely studied but not well un-
derstood (Schwarz et al. 2016). Drug-related expectation ef-
fects commonly require previous experience with the psycho-
logical effects of the respective drug, and it is likely that ex-
pectations operate by having been associated with and thus
conditioned to stimuli and expectations preceding the actual
effect (Schwarz et al. 2016). If so, the existence of
expectation-based effects does not contradict the existence of
real drug effects, as the former in fact rely on the previous
experience of the latter. From that perspective, expectation-
based effects and drug-induced effects are likely to have com-
parable impact on psychological functions, presumably even
through the same physiological means. Accordingly, while we
cannot definitely exclude that the effects we observed actually
required the present intake of the drug, they even in the worst
case are likely to rely on the previous intake and likely to
reflect the effects of that previous intake.
Notwithstanding these caveats, the outcome pattern of the
present study is consistent with the idea that microdosing
psychedelic substances improves both divergent and conver-
gent thinking. The fact that intelligence was not improved
suggests that this effect was rather selective, but the possi-
bility remains that the Raven was less sensitive to the inter-
vention than the other measures were. It is tempting to in-
terpret our observations on divergent thinking in the context
of recent suggestions that behavior drawing on flexibility
and novelty benefits from a reduction of cognitive top-
down control (Cools and D’Esposito 2009, 2011; De Dreu
et al. 2008; Dreisbach and Goschke 2004; Hommel 2015;
Baas et al. 2008). According to this view, creativity tasks
can be assumed to draw on two distinct, presumably oppos-
ing cognitive processes: flexibility is characterized by broad-
ening the attentional scope, which enables individuals to
generate many divergent ideas, while persistence is associ-
ated with a narrower attentional scope, thus allowing indi-
viduals to focus on one creative idea at a time (De Dreu
et al. 2008; Hommel 2015). Some of the previous empirical
dissociations of persistence and flexibility were related to
dopaminergic functioning, such as in behavioral genetic
studies demonstrating that polymorphisms supporting effi-
cient dopaminergic functioning in the frontal cortex promote
persistence while polymorphisms supporting striatal dopami-
nergic functioning promote flexibility (e.g., Reuter et al.
2006; Zabelina et al. 2016; for an overview, see Hommel
and Colzato 2017). This strengthens the view that frontal
and striatal dopaminergic pathways are involved in persis-
tence and flexibility. If we assume that convergent thinking
relies more on frontal persistence while divergent thinking
relies more on striatal flexibility, our outcomes raise the
question how an intervention can manage to improve both
convergent and divergent thinking.
Classical hallucinogens, including psilocybin, belong to a
group of tryptamines that are thought to exert their primary
psychedelic effects through activity at the serotonergic 5-
HT2A receptor (Vollenweider and Kometer 2010). Of particu-
lar interest in this regard are findings from animal studies
showing that 5-HT2A agonist activity (Halberstadt 2015) cor-
relates with an increase in associative learning (Harvey 2003)
and improvements in the ability to adapt behavior more flex-
ibly (Bari et al. 2010; Boulougouris et al. 2008). Moreover,
studies in humans have shown that the administration of psy-
chedelics is associated with an increase in the personality trait
BOpenness^ (MacLean et al. 2011) and that psychedelics can
induce a reduction in symptoms associatedwith rigid behavior
and thought patterns observed in obsessive-compulsive disor-
der (Moreno et al. 2006) and depression (Carhart-Harris et al.
2016a, b; Grob et al. 2011). Such findings could be tentatively
interpreted to imply that psilocybin facilitates more flexible,
less constrained kinds of cognition (Carhart-Harris et al.
2016a, b).
The 5-HT2A receptors are widely distributed in in the brain
and especially so in high-level prefrontal and associative cor-
tex—regions important for learning andmemory retrieval, this
is likely to have important functional implications (Carhart-
Harris and Nutt 2017; Zhang and Stackman 2015). For in-
stance, postsynaptic 5-HT2A receptor activation was shown
to be associated with improvements in certain aspects of cog-
nition (Gimpl et al. 1979; Harvey 1995, 2003; Harvey et al.
2004, 2012; Romano et al. 2010; Zhang and Stackman 2015;
Zhang et al. 2016) as well as an extinction of previously
learned response patterns (Zhang et al. 2013). However, it is
important to note that function of the 5-HT system remains
Belusive^ given the inherent complexity of the serotonin sys-
tem and more research has to be conducted in this regard to
determine its function (Dayan and Huys 2009; Carhart-Harris
and Nutt 2017).
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While the assumption of a link between the use of psyche-
delics and an unconstrained brain state fits well with our find-
ings on divergent thinking, it does not seem to be consistent
with our observations on convergent thinking. Microdosing
improved performance on the PCT, suggesting that it pro-
motes convergent thinking. Note that this observation con-
trasts with previous findings by Kuypers et al. (2016), who
reported that Ayahuasca, also a 5-HT2A agonist, impaired per-
formance on convergent thinking tasks. We believe this dis-
crepancy could be a result of the difference in relative dosage.
Kuypers et al. (2016) investigated participants after the intake
of large doses of Ayahuasca, which is hardly comparable to
the microdoses used in the present study. Previous research
has shown a relationship between 5-HT2A receptor activity
and goal-directed behavior likely due to indirect modulation
of DA release (Vollenweider et al. 1999; Sakashita et al. 2015;
Dalley et al. 2002; Boureau and Dayan 2011). Dopamine-
related adaptive behavior follows an inverted U shape (van
Velzen et al. 2014), suggesting that smaller doses, such as
the microdoses ingested by the participants in our current
study, are more likely to move participants towards the most
efficient mid-zone of the performance function than higher
doses do (see Akbari Chermahini and Hommel 2012, for an
application of this rationale on the impact of dopaminergic
manipulations on creativity). Indeed, based on self-reports,
an online study by Fadiman and Krob (2017) suggests that
microdosing could enhance motivation and focus, and reduce
distractibility and procrastination—which seems consistent
with our observation of improved convergent thinking.
These considerations suggest that microdoses truffle, and
perhaps 5-HT2A agonist in general improve processes that are
shared by convergent and divergent thinking—irrespective of
the existing differences. Indeed, both convergent and diver-
gent thinking tasks rely to some degree on persistence and top-
down control and to some degree on unconstrained flexibility
(Hommel 2015). While convergent thinking tasks emphasize
persistence over flexibility, and divergent-thinking tasks em-
phasize flexibility over persistence, they both require partici-
pants to keep in mind particular search criteria, which they
need to test against candidate items in memory (a skill that
relies on persistence and top-down control), and to search
through novel and often unfamiliar items considered for this
test (a skill that relies on flexibility). The tasks thus present
participants with a dilemma, which can only be solved by
finding a reasonable balance between the antagonistic skills;
that is, to be persistent and flexible at the same time, or at least
in quick succession. Microdosing therefore might promote the
speed or smoothness of switching between persistence and
flexibility—an ability that Mekern et al. (2019a, b) refer to
as Badaptivity.^ Taken together, whereas large doses of psy-
chedelics might induce an hyper-flexible mode of brain func-
tioning, and possibly a breakdown of control (Carhart-Harris
et al. 2014), microdosesmay be able to drive brain functioning
towards an optimal, highly adaptive balance between persis-
tence and flexibility.
Limitations
It is important to consider the limitations of our study. The
experiment was carried out Bin the field,^ which offers the
benefits of studying more natural effects of microdosing, but
also has the disadvantage of allowing less experimental control
than in a laboratory setting. We used a quasi-experimental
design, which limits some of the conclusions that can be drawn
from our study. Neither the participants nor the researchers
were blind to the manipulation and, as all participants con-
sumed a microdose of psychedelic truffles, we were unable
to collect data from a control group—which in this particular
context would have been hard to conceive anyway. Relatedly,
the absence of a placebo condition prevented any kind of ran-
domization of the administered substance. Participants were
not randomly selected due to the nature of the event, resulting
in a self-selection bias, and limiting the generalizability of our
findings. While we have argued that previous findings render
the possibility of learning effects unlikely, it is also true that we
were unable to quantify possible learning effects in the present
study. Moreover, the absence of a control group did not allow
us to identify and quantify possible placebo/expectation ef-
fects. Even though we have argued that this need not under-
mine our conclusions, future studies should definitely consider
expectation/placebo effects, not only as a possible confound
but also as a useful replacement of the actual drug. Another
possible objection might be that mood might have contributed
to our findings. Indeed, it is well known that divergent thinking
benefits from positive mood (Ashby et al. 1999; Baas et al.
2008; Davis 2009), providing a possible confound regarding
the effects we observed on our divergent thinking task.
However, given that we also found positive effects for conver-
gent thinking, which has not shown to benefit from positive
mood, would not fit with a mood-related interpretation.
Moreover, the well-established association between serotonin
levels and depression (Neumeister 2003; Baldwin and Rudge
1995) suggests that mood should be considered the phenome-
nological expression of a particular serotonin level (arguably in
combination with other factors) rather than an independent
factor that can moderate the impact of changes in serotonin
levels on cognitive performance. In retrospect, we also ac-
knowledge that perceived strength of drug effect would have
been a valuable measure to assess as it could have played some
role in our outcome measures.
Furthermore, it has been shown that in contrast, however,
positive mood negatively predicts convergent thinking perfor-
mance, which in our study improved after ingestion of the
psychedelic truffles. Future studies should seek to validate
our findings using a lab-based randomized double-blind
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placebo-controlled experimental designs and take the subjec-
tive strength of the experience into account as a covariate.
Conclusion
Whereas large doses of psychedelics can introduce a range of
undesirable side effects, microdoses of psychedelic substances
might prove to be a promising alternative that could eliminate
the risks of challenging experiences (sometimes referred to as
a Bbad trips^) while maintaining the potential benefits of psy-
chedelic substances on human emotion and cognition. The
current naturalistic study is the first to quantitatively show that
microdosing psychedelics could improve creative perfor-
mance, possibly bymeans of inducing a state of unconstrained
thought allowing for increased novel idea generation. We
hope that our findings will stimulate further research into the
beneficial effects of microdosing psychedelics. Apart from its
benefits as a potential cognitive enhancement technique,
microdosing could be further investigated for its therapeutic
efficacy as to slow down cognitive decline or help individuals
who suffer from rigid thought patterns or behavior such as
individuals with depression or obsessive-compulsive disorder.
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